Associated Papers
The impact of an URAT1 polymorphism on the losartan treatment of hypertension and hyperuricemia.
Wu L et al.
Journal of Clinical Laboratory Analysis, 2021
Evaluation of the Influence of Genetic Variants of SLC2A9 (GLUT9) and SLC22A12 (URAT1) on the Development of Hyperuricemia and Gout.
Pavelcova K et al.
Journal of Clinical Medicine, 2020
Amplicon targeted resequencing for SLC2A9 and SLC22A12 identified novel mutations in hypouricemia subjects.
Zhou Z et al.
Molecular Genetics & Genomic Medicine, 2019
31131560 (PubMed )
Supplement: MGG3-7-e00722-s002.xlsx › sheet_2
Discovery of URAT1 SNPs and association between serum uric acid levels and URAT1.
Cho SK et al.
Bmj Open, 2015
The genome as pharmacopeia: association of genetic dose with phenotypic response.
Wadhawan S et al.
Biochemical Pharmacology, 2015
Absence of the SLC22A12 gene mutation in Turkish population with primary gout disease.
Yakut S et al.
Rheumatology International, 2013
The genetics of hyperuricaemia and gout.
Reginato AM et al.
Nature Reviews. Rheumatology, 2012
G109T polymorphism of SLC22A12 gene is associated with serum uric acid level, but not with metabolic syndrome.
Jang WC et al.
Rheumatology International, 2012
Multiple single nucleotide polymorphisms in the human urate transporter 1 (hURAT1) gene are associated with hyperuricaemia in Han Chinese.
Li C et al.
Journal of Medical Genetics, 2010
High-resolution melting analysis for the rapid detection of an intronic single nucleotide polymorphism in SLC22A12 in male patients with primary gout in China.
Guan M et al.
Scandinavian Journal of Rheumatology, 2009
Association of the human urate transporter 1 with reduced renal uric acid excretion and hyperuricemia in a German Caucasian population.
Graessler J et al.
Arthritis and Rheumatism, 2006
Analyses of coding region polymorphisms in apical and basolateral human organic anion transporter (OAT) genes [OAT1 (NKT), OAT2, OAT3, OAT4, URAT (RST)].
Xu G et al.
Kidney International, 2005
Select a paper to view details